measurement
The study recruited 32 ovarian cancer survivors (15 early stage, 17 advanced stage) who had completed adjuvant local and systemic treatments at least 12 months prior with no evidence of recurrence, alongside 32 healthy controls.

Authors

Sources

Referenced by nodes (1)